首页> 外文期刊>European Chemical Bulletin >In-Silico Analysis of Different Plant Protein and their Essential Compound with Sulfonylurea binding protein of β-Cells of Homo sapiens for curing Diabetes Mellitus Type II disease
【24h】

In-Silico Analysis of Different Plant Protein and their Essential Compound with Sulfonylurea binding protein of β-Cells of Homo sapiens for curing Diabetes Mellitus Type II disease

机译:智人β细胞磺酰脲结合蛋白与不同植物蛋白及其必需化合物的硅酮分析,用于II型糖尿病的治疗

获取原文
           

摘要

Normal 0 Diabetes (type-2) is a chronic disorder affecting millions people all over the world. The disease is associated with long-term dysfunction, damage, and failure of various organs thus, affects almost every physiological system of the body. The chronic insulin resistance, progressive decline in β-cell function or increased rate of cell death results decreased insulin production and finally leads the disease. The sulfonylurea is known to regulate blood glucose homeostasis but have a characteristic profile of side effects. Some medicinal plant have showed hypoglycemic activities but the exact mechanism of action of these drugs at cellular level is yet not known and thus no better formulation of indigenous medicine could be developed till date for the treatment of type-2 diabetes. Therefore, the present study has been done to investigate the effect of the indigenous drugs, in-silico on the diabetic receptor, with a view to observe their effect on β-cell which could be helpful for the development of better formulation for the treatment of diabetes. Now days most of the drugs used in the treatment of type-2 diabetes either target the sulfonylurea receptor stimulating insulin release. Targeting of sulfonylurea may provide an important help for the development of drugs against type-2 diabetes. However, absence of tertiary structure of sulfonylurea limits the possibilities of structure based drug designing. In the present work we have explore the 3D structure of sulfonylurea receptor using homology approach. Based on the active sites we have screened the essential compound of Indigenous plants as a inhibitor as well as plant protein against modelled protein using iGEMDock 2.1 and Hex6.0 Cuda softwares. The Lead compound of plant as well as plant protein molecule would be scaled out on the basis of binding efficiency, starting from higher to lower and given the preference compare with the other one.
机译:正常的0型糖尿病(2型)是一种慢性疾病,影响了全世界数百万人。该疾病与各种器官的长期功能障碍,损害和衰竭有关,因此几乎影响了人体的每个生理系统。慢性胰岛素抵抗,β细胞功能进行性下降或细胞死亡速率增加导致胰岛素产生减少,最终导致该病。已知磺酰脲调节血糖稳态,但具有副作用的特征。一些药用植物已经显示出降血糖活性,但是这些药物在细胞水平上的确切作用机理尚不清楚,因此迄今为止尚无更好的本地药物制剂可用于治疗2型糖尿病。因此,本研究已经完成,以研究硅酮类药物对糖尿病受体的作用,以期观察其对β细胞的作用,这可能有助于开发更好的治疗糖尿病的药物。糖尿病。如今,用于治疗2型糖尿病的大多数药物都以磺酰脲受体刺激胰岛素释放为目标。靶向磺酰脲可能为开发抗2型糖尿病的药物提供重要帮助。然而,不存在磺酰脲的三级结构限制了基于结构的药物设计的可能性。在目前的工作中,我们已经使用同源性方法探索了磺酰脲受体的3D结构。根据活性位点,我们使用iGEMDock 2.1和Hex6.0 Cuda软件筛选了作为抑制剂的本土植物必需化合物以及针对建模蛋白质的植物蛋白质。植物的前导化合物以及植物蛋白分子将在结合效率的基础上按比例放大,从高到低开始,并给予优先选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号